Retatrutide (Triple Hormone Receptor Agonist) 20MG
Third Party TestedRetatrutide is an investigational synthetic peptide sequence engineered for cutting-edge metabolic research models. As a triple receptor agonist, it targets glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors (GCGR). This multi-pathway mechanism allows researchers to observe the combined downstream effects of tri-agonist signaling on energy expenditure, lipid oxidation, and nutrient partitioning. It serves as an advanced comparative tool for studying multi-hormone metabolic regulation in laboratory environments.
Specification Profile:- Form: Lyophilized (Freeze-Dried) crystalline powder
- Purity Level: Verified ≥98% via independent mass spectrometry (See batch paperwork)
- Storage Matrix: Store long-term at -20°C to preserve structural integrity. Protect from moisture.
- >98% Purity
- Research Grade
- COA Verified
- Third-Party Tested
Batch Testing & Certificate of Analysis
Every batch we sell is independently tested via HPLC and mass spectrometry to verify identity and purity. Certificates of Analysis (COAs) are available for download on individual product pages.
To protect our sourcing relationships, we redact our testing partner's name, contact details, and any QR codes or verification links from the COAs we publish. Purity and identity results are shown in full and unaltered.
